Tag: ocular GVHD specialist India

Travelling To India for Eye Care

Travelling to India for eye treatment? Travel for medical care is not simply about finding treatment. It is about finding the right diagnosis, understanding your options, and making important decisions with confidence. Dr Shibal Bhartiya provides specialist eye care for international patients seeking expert evaluation, second opinions, advanced diagnostics, and long-term management of complex eye conditions.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Expert Eye Care in India for Patients Seeking Clarity, Confidence, and Specialist Opinion

Glaucoma • Neuro-Ophthalmology • Dry Eye & Ocular Surface Disease • Complex Eye Care

Patients travel from the UK, USA, UAE, Singapore, Bangladesh, Nepal, East Africa, and across South Asia for consultations focused on careful assessment, evidence-based recommendations, and clear communication.

25+ Years Experience | 200+ Publications | 28 Textbooks | 1,500+ Five-Star Reviews | International Patients from 20+ Countries | 40000+ patients

Why International Patients Choose Dr Shibal Bhartiya

A Specialist Perspective for Complex Problems

Many patients seeking international consultations are not looking for another routine eye examination.

They are seeking answers to questions such as:

  • Am I actually progressing?
  • Do I really need surgery?
  • Why do my symptoms not match my test results?
  • Has something important been missed?
  • Why am I still struggling despite treatment?
  • Should I seek a second opinion before making a major decision?

Our consultations are designed to answer these questions through detailed evaluation, advanced diagnostics, and careful clinical interpretation.

Areas of Special Expertise

Glaucoma

Glaucoma is often diagnosed late because patients may continue seeing well while irreversible damage accumulates silently.

Dr Bhartiya’s glaucoma practice focuses on:

  • Early glaucoma diagnosis
  • Glaucoma suspects and risk assessment
  • Progression analysis
  • Normal tension glaucoma
  • Complex glaucoma management
  • Surgical decision-making
  • Second opinions before surgery
  • Long-term vision preservation strategies

Many international patients seek consultation after receiving conflicting advice or when they are uncertain whether treatment escalation is truly necessary.

You can read more about glaucoma here

Neuro-Ophthalmology

Neuro-ophthalmology bridges the gap between ophthalmology and neurology.

Common reasons for referral include:

  • Optic nerve disorders
  • Unexplained visual loss
  • Visual field abnormalities
  • Pituitary-related visual problems
  • Double vision
  • Intracranial hypertension
  • Neurological causes of visual symptoms
  • Complex diagnostic uncertainty

Patients are often referred after multiple consultations when symptoms, scans, and examinations do not fit together neatly.

You can read more about neuro-ophthalmology care here

Dry Eye & Ocular Surface Disease

Many patients with ocular surface disease have been treated repeatedly without understanding the underlying drivers of their symptoms.

Areas of focus include:

  • Chronic dry eye disease
  • Meibomian gland dysfunction
  • Ocular surface inflammation
  • Computer-related eye strain
  • Autoimmune ocular surface disease
  • Refractory dry eye
  • Ocular GVHD
  • Complex ocular discomfort syndromes

The goal is not simply prescribing more drops, but understanding why symptoms persist.

You can read more about ocular surface diseases including dry eye, and allergies, here

Comprehensive Ophthalmology & Diagnostic Second Opinions

Not every patient arrives with a diagnosis.

Many simply know that something is wrong.

We frequently evaluate patients seeking answers regarding:

  • Unexplained visual symptoms
  • Diagnostic uncertainty
  • Cataract and glaucoma overlap
  • Complex treatment decisions
  • Risk assessment before intervention
  • Long-term monitoring plans

Explore Our Specialist Eye Care Services

International patients often arrive with a diagnosis, a recommendation, or simply a concern that something is being missed.

While glaucoma, neuro-ophthalmology, and ocular surface disease are areas of particular expertise, every patient journey is different. Explore our specialist services below to better understand your condition and the options available.

Glaucoma Care

Glaucoma can cause permanent vision loss before symptoms become obvious. Learn about glaucoma diagnosis, risk assessment, progression monitoring, treatment options, and specialist second opinions.

Explore Glaucoma Care →

Neuro-Ophthalmology

Visual symptoms are not always caused by the eye itself. Neuro-ophthalmology evaluates disorders affecting the optic nerve, visual pathways, eye movements, and the connection between the eye and brain.

Explore Neuro-Ophthalmology →

Dry Eye & Ocular Surface Disease

Persistent irritation, burning, watering, fluctuating vision, and discomfort often require a deeper evaluation than routine eye examinations provide. Learn more about dry eye disease, meibomian gland dysfunction, ocular GVHD, and ocular surface disorders.

Explore Dry Eye & Ocular Surface Disease →

Second Opinions

Many patients seek reassurance before surgery, treatment escalation, or major decisions. A specialist second opinion can provide clarity, confirm a diagnosis, or identify alternative approaches.

Explore Second Opinions →

Advanced Diagnostic Testing

Accurate diagnosis depends on more than a single test result. Learn how OCT imaging, visual field analysis, optic nerve evaluation, and ocular surface assessment contribute to clinical decision-making.

Explore Advanced Diagnostics →

Comprehensive Eye Care

Not every patient arrives with a diagnosis. Some simply know that their vision has changed or that something does not feel right. Explore common eye conditions, symptoms, and specialist evaluation pathways.

Explore Comprehensive Eye Care →

Whether you are seeking a second opinion, treatment recommendations, or answers to a complex diagnostic question, our goal is to help you understand your condition clearly and make confident decisions about your eye health.

Popular Searches: glaucoma specialist India, neuro-ophthalmologist India, dry eye specialist India, glaucoma second opinion India, ocular surface disease specialist India, international eye specialist India, advanced eye care India, ophthalmologist for international patients.

International Patient Journey

Step 1: Send Your Records

Before travelling, patients may share:

  • Previous consultation notes
  • OCT scans
  • Visual field reports
  • MRI or CT reports
  • Surgical recommendations
  • Current medication lists

This allows preliminary review and helps ensure efficient use of consultation time.

Step 2: Pre-Visit Review

Records are reviewed before your appointment whenever possible.

This means consultations begin with context rather than starting from zero.

Step 3: Specialist Evaluation

Consultations may include:

  • Comprehensive examination
  • Advanced imaging
  • Functional testing
  • Risk assessment
  • Discussion of treatment options
  • Clarification of previous findings

Most investigations can be completed in a single visit.

Step 4: Written Clinical Opinion

Patients receive:

  • Detailed findings
  • Interpretation of investigations
  • Diagnosis (where possible)
  • Treatment recommendations
  • Follow-up strategy

Reports can be shared with treating doctors in the patient’s home country to support continuity of care.

Step 5: Ongoing Follow-Up

Many eye conditions require continuity rather than isolated intervention.

Where appropriate, follow-up planning may include:

  • Remote review of reports
  • Communication with local specialists
  • Monitoring recommendations
  • Long-term management planning

Why Patients Travel to India

India offers access to:

  • Advanced ophthalmic diagnostics
  • Internationally recognised specialists
  • Minimal waiting times
  • Comprehensive investigations in one location
  • Cost-effective care compared with many Western healthcare systems

Many patients are able to complete evaluation and decision-making within a short visit.

About Dr Shibal Bhartiya

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist with over 25 years of clinical experience. Her work combines clinical care, research, education, and international collaboration.

Highlights include:

  • Fellowship-Trained Glaucoma Specialist
  • Mayo Clinic Research Collaborator
  • 200+ Scientific Publications
  • 90+ PubMed-Indexed Papers
  • 28 Edited Textbooks
  • Editor-in-Chief, CLEVER
  • Executive Editor, Journal of Current Glaucoma Practice
  • International Speaker and Research Collaborator

Languages Spoken

To make complex medical discussions easier for international patients, consultations may be conducted with an interpreter, or facilitator if required. However, Dr Shibal Bhartiya speaks several languages:

  • English
  • Hindi
  • Urdu
  • French
  • Bangla (conversational)
  • Arabic (basic conversational)
  • Persian / Farsi (basic conversational)

Medical records and formal clinical documentation are provided in English, and may be provided in Hindi, French or Urdu on request .

Frequently Asked Questions

Can I send my reports before travelling?

Yes. Sharing reports beforehand helps determine what additional testing may be needed and allows more focused consultations.

Can I obtain a second opinion without surgery?

Absolutely. A large proportion of international patients seek clarity and confirmation before making treatment decisions.

How long should I stay in India?

Most second-opinion evaluations can be completed within 2–3 days. Surgical patients may require longer depending on the procedure.

Will my doctor at home receive a report?

Yes. With your permission, a detailed written opinion can be shared with your treating physician.

Do you assist with medical visa documentation?

Supporting medical documentation can be provided where required.

Send Your Reports Before You Travel

If you are considering travelling to India for glaucoma, neuro-ophthalmology, dry eye treatment, or a specialist second opinion, the process can begin before you leave home.

Send your reports, scans, or questions for review.

Dr Shibal Bhartiya
Glaucoma • Neuro-Ophthalmology • Advanced Eye Care • Second Opinion

🌐 www.drshibalbhartiya.com
📞 +91 88826 38735

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Ocular GVHD: Eye Problems After BMT

Ocular GVHD (Graft-Versus-Host Disease) is an immune-mediated condition that develops after a bone marrow or stem cell transplant. Donor immune cells attack the tear glands and eye surface, causing dry eyes, burning, redness, and light sensitivity. Early specialist evaluation and treatment protect the eye surface and preserve vision long-term.

Ocular GVHD affects your eyes after a bone marrow or stem cell transplant. Donor immune cells target your tear glands and corneal surface. The condition can appear weeks, months, or even years after transplant. Early identification changes outcomes significantly.

This condition sits at the intersection of haematology and ophthalmology. Your transplant team and your eye doctor need to work together. Regular eye review is part of post-transplant care, not an optional extra.

What Is Ocular GVHD?

Graft-Versus-Host Disease (GVHD) is an immune-mediated inflammatory reaction. It occurs when donor immune cells recognise the recipient’s tissues as foreign and attack them. Several organs can be affected, including the skin, liver, gut, and eyes.

The eye is more commonly affected in chronic GVHD, but acute GVHD can also involve the ocular surface. When the eyes are involved, the condition is called Ocular GVHD.

What Are the Symptoms of Ocular GVHD?

Symptoms range from mild to severe. They include one or more of the following:

  • Dry eyes and a persistent gritty sensation
  • Burning and irritation
  • Redness
  • Excessive watering and tearing
  • Light sensitivity
  • Blurred or fluctuating vision

In children, obvious complaints are often absent. Parents may notice excessive eye rubbing, light sensitivity, or reluctance to open the eyes in bright light.

Do not dismiss vague symptoms such as discomfort, scratchiness, or eye fatigue. These can be early signs of ocular GVHD. Your transplant surgeon may request an eye evaluation even when you have no symptoms at all.

How Is Ocular GVHD Diagnosed?

A complete eye examination is the starting point. This includes visual acuity testing, refraction, slit-lamp examination, and tear film assessment.

Your eye doctor will also perform specific tests to evaluate the ocular surface. These include the Schirmer’s test, and staining of the cornea with fluorescein and/or Rose Bengal dyes. These tests assess tear production and identify surface damage not visible to the naked eye.

How Is Ocular GVHD Treated?

Management focuses on controlling dryness, reducing inflammation, preventing infection, and protecting the cornea from scarring.

Systemic drugs given by your bone marrow transplant team for the rest of the body often do not adequately treat the eyes. Your eye doctor will likely recommend one or more of the following:

  • Lubricating eye drops to improve comfort and reduce corneal damage
  • Steroid eye drops to control inflammation and prevent scarring
  • Antibiotic eye drops to prevent or treat secondary infection
  • Autologous serum eye drops to support healing of the ocular surface
  • Cyclosporine eye drops to reduce the immune-mediated reaction

Treatment is adjusted over time based on disease activity and symptom burden. This is a condition that needs long-term follow-up, not a single course of treatment.

How is Ocular GVHD Classified?

Acute ocular GVHD develops during or soon after systemic acute GVHD and is characterized by sudden inflammation, redness, pain, tearing, photophobia, and conjunctival involvement.

Chronic ocular GVHD is a long-term immune-mediated disease that typically presents with persistent dry eye, burning, grittiness, fluctuating vision, meibomian gland dysfunction, and progressive ocular surface damage.

Acute-on-chronic ocular GVHD occurs when a patient with established chronic ocular GVHD experiences a sudden inflammatory flare, causing a rapid worsening of symptoms such as redness, pain, light sensitivity, and ocular surface inflammation on top of their baseline chronic dry eye disease.

Who Is Most at Risk?

Anyone who has undergone a bone marrow or stem cell transplant can develop ocular GVHD. Risk is higher in:

  • Patients with chronic GVHD affecting other organs
  • Patients on prolonged immunosuppression
  • Those with a history of acute GVHD

Children who have had transplants are a particularly vulnerable group. Symptoms may be subtle. Eye problems can quietly affect reading, school performance, and daily comfort without an obvious complaint from the child.

When to See a Specialist

See an eye specialist promptly if any of the following apply.

You or your child has had a bone marrow or stem cell transplant, and eye symptoms have appeared at any point after — not only in the early weeks.

Symptoms are present but mild. Mild ocular GVHD does not stay mild without treatment. Surface damage accumulates quietly.

Your transplant team has not yet arranged an ophthalmic review. Ask for one. It should be part of standard post-transplant follow-up.

Vision feels “off” even though a recent check showed normal acuity. Tear film instability affects functional vision. Standard acuity testing does not capture it.

You have been given lubricants but the symptoms persist. This is a signal for specialist evaluation, not a reason to try a different brand of drops.

What Doctors Sometimes Miss

Ocular GVHD is underdiagnosed. Several patterns come up repeatedly in practice.

Symptoms labelled as “just dry eyes.” Post-transplant dryness is not routine dry eye. The mechanism is different, the severity is higher, and the risk of corneal scarring is real. It needs specialist evaluation, not over-the-counter drops.

Children who don’t complain. A child who rubs their eyes, squints, or avoids reading is not always being difficult. These are ocular surface symptoms. Parents and transplant teams both need to watch for them.

The quiet chronic phase. Acute GVHD gets attention. Chronic ocular GVHD can smoulder for months with low-grade symptoms. Vision may remain measurably normal while the surface continues to deteriorate. Symptom absence does not mean the eye is safe.

Delayed referral from transplant teams. Eye review is sometimes requested only after symptoms become severe. Baseline ophthalmic evaluation before or shortly after transplant is better practice. Earlier review means earlier intervention.

Ocular GVHD: Symptoms, Causes, and When to Worry

SymptomWhat It MeansWhen to Worry
Dryness and grittinessTear gland damage from donor immune cellsIf persistent or worsening despite lubricants
Burning and irritationOcular surface inflammationIf affecting daily activities, reading, or sleep
RednessConjunctival involvementIf sudden, severe, or accompanied by pain
Light sensitivityCorneal surface damageIf debilitating or new after a settled period
Blurred or fluctuating visionTear film instability or corneal changesAlways warrants prompt specialist review
Eye rubbing in childrenMay be the only visible signIf post-transplant, refer early — do not wait
Watering and tearingReflex response to surface drynessIf combined with other symptoms

FAQs

Can ocular GVHD occur without dry eye symptoms?

Yes. Some patients present with redness, light sensitivity, or blurred vision rather than classic dryness. In children, the only sign may be eye rubbing or reluctance to be in bright light. A specialist examination is more reliable than symptom-based self-assessment.

Does ocular GVHD go away on its own?

Occasionally it settles with time, but many patients need long-term treatment. Stopping treatment early often leads to flare-ups. Your eye doctor will guide when and how to taper any medications.

Can both eyes be affected?

Yes. Ocular GVHD typically affects both eyes, though one side may be more symptomatic than the other.

Is teleconsultation available for ocular GVHD follow-up?

Yes. If you live outside Gurgaon or are unable to travel, teleconsultation is available to support ongoing management in partnership with your local eye doctor.

This page is part of the Dry Eye Disease hub. Read about our full approach to GVHD, dry eyes, and children’s eye care. Please also read the Pediatric Eye Care hub.

Here’s another heartening patient story: A young boy and his love for trucks, and Chronic GVHD and Success Stories.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Read a patient story:

Ocular GVHD in Children

Chronic GVHD and Success Stories

Ocular GVHD

Posted on by Dr Shibal Bhartiya

Ocular GVHD or GVHD of the eye is an immune mediated inflammation that may affect patients who have had bone marrow transplants.